Computational Life


Computational Life is dedicated to transforming healthcare outcomes through advanced computational modeling. Specializing in cardiogenic shock management, regulatory support, and R&D advising, the company develops mathematical models that provide innovative solutions at the intersection of clinical care, regulatory strategy, and research development. Their approach combines expertise with cutting-edge technology to address complex healthcare challenges, aiming to improve patient outcomes, streamline regulatory processes, and accelerate medical research.

Industries

Health Care
Health Diagnostics
Medical
Medical Device
Simulation
Software
Research Services

Nr. of Employees

small (1-50)

Computational Life


Products

Computational physiological modeling platform

A modular analytical platform that builds physiologically based digital representations of individuals to simulate treatment and disease dynamics for clinical, R&D, and regulatory use cases.

Altegos

Altegos is a robust analytical technology based on mathematical models capable of generating a digital twin of an individual, describing subject-specific whole-body physiology to interpret intricate interactions between therapeutic interventions and human physiology.

In-Silico Regulatory Support Modeling

In-silico modeling solutions to create detailed evidence and reports for notified bodies submission processes for drugs and medical devices.

Regulatory Support Services

A comprehensive suite of regulatory services designed to guide drug and medical device submissions through preliminary consultation, in-silico evidence generation, and compliant documentation support.

In-Silico Clinical Trials

Simulation capabilities offering a faster, more ethical, and cost-effective way to evaluate drug and device effectiveness and safety.

Clinical Scenario Modeling

Advanced modeling diving deep into individual or population studies to bring precision to clinical research and offer insights into patient responses and treatment efficacies.

View All Products

Services

Model‑based predictive support to simulate treatment options and patient hemodynamic responses in cardiogenic shock.

Preparation of in‑silico evidence packages and reports aligned with regulatory guidelines to assist notified body submissions for medical devices and drugs.

Consulting services from project inception through in‑silico evidence generation, including integration with existing models and bespoke model development.

Expertise Areas

  • Clinical decision support
  • Cardiovascular hemodynamics modeling
  • In‑silico clinical trial design
  • Model validation and verification
  • Show More (4)

Key Technologies

  • Multiscale physiological modeling
  • Digital twin of patient physiology
  • In‑silico clinical trials
  • Uncertainty quantification (UQ)
  • Show More (7)

News & Updates

A scientific paper published in ASAIO Journal on the validation of a multiscale computational model for cardiogenic shock.

A research paper published in Bioimpacts on the function of arteries and veins during simulated cardiac arrest.

Presentations at ASAIO and ESAIO Congresses on the characterization of a multiscale model for cardiogenic shock.

Distributed medical intervention testing on a digitally simulated patient. PCT phase

A patent related to distributed medical intervention testing on a digital patient.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.